Little Green Pharma Ltd (ASX: LGP) has successfully expanded its cultivation facility in Western Australia allowing the production of up to 110,000 bottles of medicinal cannabis oil per annum.
Expanded state-of-the-art growing facilities
The expanded cultivation facility will have the capacity to produce sufficient cannabis flower to allow LGO to lift its production capacity by approximately ten times the current figures.
Commissioned on time and on budget, the expanded cultivation facility features nine new flowering rooms with a number of state-of-the-art automated technologies to enhance cultivation effectiveness, such as rolling benches, computer-timed LED lighting, climate control, and irrigation control.
Managing Director, Fleta Solomon, said the facility will operate under its expanded Medicinal Cannabis Licence, which was granted by the Office of Drug Control and is valid until March 10, 2021.
Subject to final regulatory approval and the granting of an expanded Medicinal Cannabis Permit by the ODC, including any potential delay to the permitting process due to the impact of COVID-19, LGP expects first planting at its expanded cultivation facility to take place in Q2CY2020.
It is pleasing to see the hard work by our staff come to fruition through the completion of this expanded cultivation facility,” Ms Solomon said.
“The company has signed sales agreements into some of the world’s largest medicinal cannabis markets, including Germany and the UK, and this expanded facility represents a major milestone in enhancing our ability to improve the lives of patients in Australian and international markets.”
